Citations (99)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Alexandre M. C. Santos, Loredana G. Marcu, Chia M. Wong & Eva Bezak. (2016) Risk estimation of second primary cancers after breast radiotherapy. Acta Oncologica 55:11, pages 1331-1337.
Read now
Read now
Camilla H. Stokkevåg, Grete M. Engeseth, Liv B. Hysing, Kristian S. Ytre-Hauge, Christian Ekanger & Ludvig P. Muren. (2015) Risk of radiation-induced secondary rectal and bladder cancer following radiotherapy of prostate cancer. Acta Oncologica 54:9, pages 1317-1325.
Read now
Read now
John Ng & Igor Shuryak. (2015) Minimizing second cancer risk following radiotherapy: current perspectives. Cancer Management and Research 7, pages 1-11.
Read now
Read now
Venkata S. K. Manem, Mohammad Kohandel, David C. Hodgson, Michael B. Sharpe & Siv Sivaloganathan. (2015) The effect of radiation quality on the risks of second malignancies. International Journal of Radiation Biology 91:3, pages 209-217.
Read now
Read now
Oscar Ardenfors, Dan Josefsson & Alexandru Dasu. (2014) Are IMRT treatments in the head and neck region increasing the risk of secondary cancers?. Acta Oncologica 53:8, pages 1041-1047.
Read now
Read now
N. Patrik Brodin, Per Munck AF Rosenschöld, Marianne C. Aznar, Anne Kiil-Berthelsen, Ivan R. Vogelius, Per Nilsson, Birgitta Lannering & Thomas Björk-Eriksson. (2011) Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma. Acta Oncologica 50:6, pages 806-816.
Read now
Read now
Safora Johansen, Johan Vikström, Mari Helene Blihovde Hjelstuen, Ingvil Mjaaland, Kjell Ivar Dybvik & Dag Rune Olsen. (2011) Dose evaluation and risk estimation for secondary cancer in contralateral breast and a study of correlation between thorax shape and dose to organs at risk following tangentially breast irradiation during deep inspiration breath-hold and free breathing. Acta Oncologica 50:4, pages 563-568.
Read now
Read now
Håkan Nyström. (2010) The role of protons in modern and biologically-guided radiotherapy. Acta Oncologica 49:7, pages 1124-1131.
Read now
Read now
Safora Johansen, Luca Cozzi & Dag Rune Olsen. (2009) A planning comparison of dose patterns in organs at risk and predicted risk for radiation induced malignancy in the contralateral breast following radiation therapy of primary breast using conventional, IMRT and Volumetric modulated arc treatment techniques. Acta Oncologica 48:4, pages 495-503.
Read now
Read now
Safora Johansen, Turi Danielsen & Dag Rune Olsen. (2008) Estimated risk for secondary cancer in the contra-lateral breast following radiation therapy of breast cancer. Acta Oncologica 47:3, pages 391-396.
Read now
Read now
Bengt Glimelius. (2007) Acta Oncologica – achievements during 2006 and a look at the future. Acta Oncologica 46:1, pages 5-7.
Read now
Read now
Alexandru Daşu & Iuliana Toma-Daşu. (2005) Dose-effect models for risk – relationship to cell survival parameters. Acta Oncologica 44:8, pages 829-835.
Read now
Read now
Thomas Björk-Eriksson & Bengt Glimelius. (2005) The potential of proton beam therapy in paediatric cancer. Acta Oncologica 44:8, pages 871-875.
Read now
Read now
Articles from other publishers (86)
Y Thibaut, G Gonon, J S Martinez, M Petit, R Babut, A Vaurijoux, G Gruel, C Villagrasa, S Incerti & Y Perrot. (2023) Experimental validation in a neutron exposure frame of the MINAS TIRITH for cell damage simulation. Physics in Medicine & Biology 68:22, pages 225008.
Crossref
Crossref
Lei Zhao, Aiping Tang, Fei Long, Dong Mi & Yeqing Sun. (2023) Modeling of ionizing radiation-induced chromosome aberration and tumor prevalence based on two classes of DNA double-strand breaks clustering in chromatin domains. Ecotoxicology and Environmental Safety 259, pages 115038.
Crossref
Crossref
Amin Banaei, Bijan Hashemi & Mohsen Bakhshandeh. (2022) Estimating cancer risks due to whole lungs low dose radiotherapy with different techniques for treating COVID-19 pneumonia. Radiation Oncology 17:1.
Crossref
Crossref
Pamela Akuwudike, Adrianna Tartas, Milagrosa López-Riego, Iuliana Toma-Dasu, Andrzej Wojcik & Lovisa Lundholm. (2022) Cell Type-Specific Patterns in the Accumulation of DNA Damage Following Multifractional Radiation Exposure. International Journal of Molecular Sciences 23:21, pages 12861.
Crossref
Crossref
Antonia Hufnagl, Gracinda Johansson, Albert Siegbahn, Marco Durante, Thomas Friedrich & Michael Scholz. (2022) Modeling secondary cancer risk ratios for proton versus carbon ion beam therapy: A comparative study based on the local effect model. Medical Physics 49:8, pages 5589-5603.
Crossref
Crossref
Laila König, Juliane Hörner-Rieber, Matthew Forsthoefel, Peter Haering, Eva Meixner, Tanja Eichkorn, Anna Krämer, Thomas Mielke, Eric Tonndorf-Martini, Matthias F. Haefner, Jürgen Debus & Jonathan W. Lischalk. (2022) Secondary Malignancy Risk Following Proton vs. X-ray Radiotherapy of Thymic Epithelial Tumors: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk. Cancers 14:10, pages 2409.
Crossref
Crossref
Edward Christopher Dee & Jonathan E. Leeman. (2021) Second malignancy probabilities in prostate cancer patients treated with SBRT and other contemporary radiation techniques: Reply. Radiotherapy and Oncology 165, pages 191-192.
Crossref
Crossref
Yi Yang, Yuqiong Yang & Su Yan. (2021) Risk and survival of second primary malignancies following diagnosis of gastric mucosa-associated lymphoid tissue lymphomas: A population-based study. Current Problems in Cancer 45:6, pages 100735.
Crossref
Crossref
Tanja Eichkorn, Laila König, Thomas Held, Patrick Naumann, Semi Harrabi, Malte Ellerbrock, Klaus Herfarth, Thomas Haberer & Jürgen Debus. (2021) Carbon Ion Radiation Therapy: One Decade of Research and Clinical Experience at Heidelberg Ion Beam Therapy Center. International Journal of Radiation Oncology*Biology*Physics 111:3, pages 597-609.
Crossref
Crossref
Maximilian Y. Deng, Dominik Sturm, Elke Pfaff, Martin Sill, Damian Stichel, Gnana Prakash Balasubramanian, Stephan Tippelt, Christof Kramm, Andrew M. Donson, Adam L. Green, Chris Jones, Jens Schittenhelm, Martin Ebinger, Martin U. Schuhmann, Barbara C. Jones, Cornelis M. van Tilburg, Andrea Wittmann, Andrey Golanov, Marina Ryzhova, Jonas Ecker, Till Milde, Olaf Witt, Felix Sahm, David Reuss, David Sumerauer, Josef Zamecnik, Andrey Korshunov, Andreas von Deimling, Stefan M. Pfister & David T. W. Jones. (2021) Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/B. Nature Communications 12:1.
Crossref
Crossref
Hyunsoo Jang, Jiyeon Park, Mark Artz, Yawei Zhang, Jacob C. Ricci, Soon Huh, Perry B. Johnson, Mi-Hwa Kim, Mison Chun, Young-Taek Oh, O Kyu Noh & Hae-Jin Park. (2021) Effective Organs-at-Risk Dose Sparing in Volumetric Modulated Arc Therapy Using a Half-Beam Technique in Whole Pelvic Irradiation. Frontiers in Oncology 11.
Crossref
Crossref
Chomporn Sitathanee, Puangpen Tangboonduangjit, Mantana Dhanachai, Sawanee Suntiwong, Pornpan Yongvithisatid, Sukanya Rutchantuk, Pimolpun Changkaew, Rattana Watjiranon, Suphalak Khachonkham & Vipa Boonkitticharoen. (2021) Secondary cancer risk from modern external-beam radiotherapy of prostate cancer patients: Impact of fractionation and dose distribution. Journal of Radiation Research 62:4, pages 707-717.
Crossref
Crossref
Sophie Taylor, Pei Lim, Reem Ahmad, Ammar Alhadi, William Harris, Vasilis Rompokos, Derek D'Souza, Mark Gaze, Jennifer Gains & Catarina Veiga. (2021) Risk of radiation-induced second malignant neoplasms from photon and proton radiotherapy in paediatric abdominal neuroblastoma. Physics and Imaging in Radiation Oncology 19, pages 45-52.
Crossref
Crossref
Antonia Hufnagl, Michael Scholz & Thomas Friedrich. (2021) Modeling Radiation-Induced Neoplastic Cell Transformation In Vitro and Tumor Induction In Vivo with the Local Effect Model. Radiation Research 195:5.
Crossref
Crossref
Giorgio Cartechini, Francesco Fracchiolla, Loris Menegotti, Emanuele Scifoni, Chiara La Tessa, Marco Schwarz, Paolo Farace & Francesco Tommasino. (2020) Proton pencil beam scanning reduces secondary cancer risk in breast cancer patients with internal mammary chain involvement compared to photon radiotherapy. Radiation Oncology 15:1.
Crossref
Crossref
Marius Treutwein, Rainer Loeschel, Matthias Hipp, Oliver Koelbl & Barbara Dobler. (2020) Secondary malignancy risk for patients with localized prostate cancer after intensity‐modulated radiotherapy with and without flattening filter. Journal of Applied Clinical Medical Physics 21:12, pages 197-205.
Crossref
Crossref
Chunhui Han, An Liu & Jeffrey Y.C. Wong. (2020) Estimation of radiation-induced, organ-specific, secondary solid-tumor occurrence rates with total body irradiation and total marrow irradiation treatments. Practical Radiation Oncology 10:5, pages e406-e414.
Crossref
Crossref
Apostolos Raptis, Jakob Ödén, Oscar Ardenfors, Anna M. Flejmer, Iuliana Toma-Dasu & Alexandru Dasu. (2020) Cancer risk after breast proton therapy considering physiological and radiobiological uncertainties. Physica Medica 76, pages 1-6.
Crossref
Crossref
Laila König, Peter Haering, Clemens Lang, Mona Splinter, Bastian von Nettelbladt, Fabian Weykamp, Philipp Hoegen, Jonathan W. Lischalk, Klaus Herfarth, Jürgen Debus & Juliane Hörner-Rieber. (2020) Secondary Malignancy Risk Following Proton vs. X-ray Treatment of Mediastinal Malignant Lymphoma: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk. Frontiers in Oncology 10.
Crossref
Crossref
Hsinyuan Hung, Jengfu You, Jyming Chiang, Paoshiu Hsieh, Sumfu Chiang, Chengchou Lai, Wensy Tasi, Chienyuh Yeh, Yihjong Chern & Yujen Hsu. (2020) Clinicopathological characteristics and outcomes of metachronous rectal cancer in patients with a history of cervical cancer with and without remote radiotherapy. Medicine 99:30, pages e21328.
Crossref
Crossref
Hamid Reza Baghani & Behzad Aminafshar. (2020) In-field radiation contamination during intraoperative electron radiation therapy with a dedicated accelerator. Applied Radiation and Isotopes 155, pages 108918.
Crossref
Crossref
Kaga Gomarteli, Jens Fleckenstein, Stefanie Kirschner, Vladimir Bobu, Marc A. Brockmann, Thomas Henzler, Mathias Meyer, Philipp Riffel, Stefan O. Schönberg, Marlon R. Veldwijk, Bettina Kränzlin, Christian Hoerner, Gerhard Glatting, Frederik Wenz, Carsten Herskind & Frank A. Giordano. (2019) Radiation-induced malignancies after intensity-modulated versus conventional mediastinal radiotherapy in a small animal model. Scientific Reports 9:1.
Crossref
Crossref
Vasanthan Sakthivel, Kadirampatti M. Ganesh, Craig McKenzie, Raghavendiran Boopathy & Jothybasu Selvaraj. (2019) Second malignant neoplasm risk after craniospinal irradiation in X-ray-based techniques compared to proton therapy. Australasian Physical & Engineering Sciences in Medicine 42:1, pages 201-209.
Crossref
Crossref
Kalliopi M. Kourinou, Michalis Mazonakis, Efrosini Lyraraki, Helen Α. Papadaki & John Damilakis. (2019) Probability of carcinogenesis due to involved field and involved site radiation therapy techniques for supra- and infradiaphragmatic Hodgkin’s disease. Physica Medica 57, pages 100-106.
Crossref
Crossref
Shunsuke Yonai, Naruhiro Matsufuji & Keiichi Akahane. (2018) Monte Carlo study of out-of-field exposure in carbon-ion radiotherapy with a passive beam: Organ doses in prostate cancer treatment. Physica Medica 51, pages 48-55.
Crossref
Crossref
Vasanthan Sakthivel, Ganesh Kadirampatti Mani, Sunil Mani & Raghavendiran Boopathy. (2017) Radiation-induced second cancer risk from stereotactic ablative radiotherapy (SABR) for lung cancer: a review of planning studies. Journal of Radiotherapy in Practice 17:2, pages 194-204.
Crossref
Crossref
Camilla Hanquist Stokkevåg, Uwe Schneider, Ludvig Paul Muren & Wayne Newhauser. (2017) Radiation-induced cancer risk predictions in proton and heavy ion radiotherapy. Physica Medica 42, pages 259-262.
Crossref
Crossref
Beatriz Sánchez-Nieto, Maite Romero-Expósito, José A. Terrón & Francisco Sánchez-Doblado. (2017) Uncomplicated and Cancer-Free Control Probability (UCFCP): A new integral approach to treatment plan optimization in photon radiation therapy. Physica Medica 42, pages 277-284.
Crossref
Crossref
Gracinda Mondlane, Michael Gubanski, Pehr A. Lind, Ana Ureba & Albert Siegbahn. (2017) Comparative study of the calculated risk of radiation-induced cancer after photon- and proton-beam based radiosurgery of liver metastases. Physica Medica 42, pages 263-270.
Crossref
Crossref
Eva Bezak, Rundgham Takam, Eric Yeoh & Loredana G. Marcu. (2017) The risk of second primary cancers due to peripheral photon and neutron doses received during prostate cancer external beam radiation therapy. Physica Medica 42, pages 253-258.
Crossref
Crossref
Alexandru Dasu & Iuliana Toma-Dasu. (2017) Models for the risk of secondary cancers from radiation therapy. Physica Medica 42, pages 232-238.
Crossref
Crossref
M. Mazonakis & J. Damilakis. (2017) Cancer risk after radiotherapy for benign diseases. Physica Medica 42, pages 285-291.
Crossref
Crossref
Stephen F. Kry, Bryan Bednarz, Rebecca M. Howell, Larry Dauer, David Followill, Eric Klein, Harald Paganetti, Brian Wang, Cheng‐Shie Wuu & X. George Xu. (2017)
AAPM TG
158: Measurement and calculation of doses outside the treated volume from external‐beam radiation therapy
. Medical Physics 44:10.
Crossref
Crossref
Panayiotis Mavroidis, Georgios Komisopoulos, Courtney Buckey, Margarita Mavroeidi, Gregory P. Swanson, Dimos Baltas, Nikos Papanikolaou & Sotirios Stathakis. (2017) Radiobiological evaluation of prostate cancer IMRT and conformal-RT plans using different treatment protocols. Physica Medica 40, pages 33-41.
Crossref
Crossref
Venkata S K Manem, Mohammad Kohandel, David C Hodgson & Siv Sivaloganathan. (2017) Predictive modeling of therapy induced secondary thyroid malignancies in childhood cancer survivors. Convergent Science Physical Oncology 3:3, pages 035003.
Crossref
Crossref
Michalis Mazonakis, Efrossyni Lyraraki & John Damilakis. (2017) Second cancer risk assessments after involved-site radiotherapy for mediastinal Hodgkin lymphoma. Medical Physics 44:7, pages 3866-3874.
Crossref
Crossref
Sang-Won Kang, Tae-Suk Suh, Jin-Beom Chung, Keun-Yong Eom, Changhoon Song, In-Ah Kim, Jae-Sung Kim, Jeong-Woo Lee & Woong Cho. (2017) Comparison of dosimetric and radiobiological parameters on plans for prostate stereotactic body radiotherapy using an endorectal balloon for different dose-calculation algorithms and delivery-beam modes. Journal of the Korean Physical Society 70:4, pages 424-430.
Crossref
Crossref
Michalis Mazonakis, Antonis Tzedakis, Efrossyni Lyraraki & John Damilakis. (2016) Organ-specific radiation-induced cancer risk estimates due to radiotherapy for benign pigmented villonodular synovitis. Physics in Medicine and Biology 61:17, pages 6400-6412.
Crossref
Crossref
Camilla H. Stokkevåg, Mai Fukahori, Takuma Nomiya, Naruhiro Matsufuji, Grete May Engeseth, Liv B. Hysing, Kristian S. Ytre-Hauge, Eivind Rørvik, Artur Szostak & Ludvig P. Muren. (2016) Modelling of organ-specific radiation-induced secondary cancer risks following particle therapy. Radiotherapy and Oncology 120:2, pages 300-306.
Crossref
Crossref
Louise Murray, Joshua Mason, Ann M. Henry, Peter Hoskin, Frank-Andre Siebert, Jack Venselaar & Peter Bownes. (2016) Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer. Radiotherapy and Oncology 120:2, pages 293-299.
Crossref
Crossref
Michalis Mazonakis, Antonis Tzedakis, Efrossyni Lyraraki & John Damilakis. (2016) Radiation dose and cancer risk to out‐of‐field and partially in‐field organs from radiotherapy for symptomatic vertebral hemangiomas. Medical Physics 43:4, pages 1841-1848.
Crossref
Crossref
Uwe Schneider & Linda Walsh. (2015) Age at exposure and attained age variations of cancer risk in the Japanese A‐bomb and radiotherapy cohorts. Medical Physics 42:8, pages 4755-4761.
Crossref
Crossref
C. Timlin, D. R. Warren, B. Rowland, A. Madkhali, J. Loken, M. Partridge, B. Jones, J. Kruse & R. Miller. (2015) 3D calculation of radiation‐induced second cancer risk including dose and tissue response heterogeneities. Medical Physics 42:2, pages 866-876.
Crossref
Crossref
Richard S. Pieters, Henry Wagner, Stephen Baker, Karen Morano, Kenneth Ulin, Maria Giulia Cicchetti, Maryann Bishop-Jodoin & Thomas J. FitzGerald. (2014) The Impact of Protocol Assignment for Older Adolescents with Hodgkin Lymphoma. Frontiers in Oncology 4.
Crossref
Crossref
A Joosten, F Bochud & R Moeckli. (2014) A critical evaluation of secondary cancer risk models applied to Monte Carlo dose distributions of 2-dimensional, 3-dimensional conformal and hybrid intensity-modulated radiation therapy for breast cancer. Physics in Medicine and Biology 59:16, pages 4697-4722.
Crossref
Crossref
Georgios Komisopoulos, Panayiotis Mavroidis, Salvador Rodriguez, Sotirios Stathakis, Nikos Papanikolaou, Georgios C. Nikiforidis & Georgios C. Sakellaropoulos. (2014) Radiobiologic comparison of helical tomotherapy, intensity modulated radiotherapy, and conformal radiotherapy in treating lung cancer accounting for secondary malignancy risks. Medical Dosimetry 39:4, pages 337-347.
Crossref
Crossref
A. Dasu & I. Toma-Dasu. 2014. Comprehensive Biomedical Physics. Comprehensive Biomedical Physics
223
233
.
David J. Brenner, Igor Shuryak & Rainer K. Sachs. 2014. ALERT - Adverse Late Effects of Cancer Treatment. ALERT - Adverse Late Effects of Cancer Treatment
205
226
.
R.M. Harrison. (2013) Introduction to dosimetry and risk estimation of second cancer induction following radiotherapy. Radiation Measurements 57, pages 1-8.
Crossref
Crossref
Eui Kwan Koh, Jungju Seo, Tae Seong Baek, Eun Ji Chung, Myonggeun Yoon & Hyun-ho Lee. (2013) Estimate of the risk of radiation-induced cancers after linear-accelerator-based breast-cancer radiotherapy. Journal of the Korean Physical Society 63:1, pages 97-103.
Crossref
Crossref
Andrea Riccardo Filippi, Riccardo Ragona, Marco Fusella, Angela Botticella, Christian Fiandra & Umberto Ricardi. (2013) Changes in breast cancer risk associated with different volumes, doses, and techniques in female Hodgkin lymphoma patients treated with supra-diaphragmatic radiation therapy. Practical Radiation Oncology 3:3, pages 216-222.
Crossref
Crossref
A Quinn, L Holloway & P Metcalfe. (2013) Image guidance during breast radiotherapy: a phantom dosimetry and radiation-induced second cancer risk study. Journal of Physics: Conference Series 444, pages 012046.
Crossref
Crossref
Maite R. Expósito, Beatriz Sánchez-Nieto, José A. Terrón, Carles Domingo, Faustino Gómez & Francisco Sánchez-Doblado. (2013) Neutron contamination in radiotherapy: Estimation of second cancers based on measurements in 1377 patients. Radiotherapy and Oncology 107:2, pages 234-241.
Crossref
Crossref
Brigitte Zurl, Heidi Stranzl, Peter Winkler & Karin Sigrid Kapp. (2013) Quantification of Contralateral Breast Dose and Risk Estimate of Radiation-Induced Contralateral Breast Cancer Among Young Women Using Tangential Fields and Different Modes of Breathing. International Journal of Radiation Oncology*Biology*Physics 85:2, pages 500-505.
Crossref
Crossref
Andreas Joosten, Oscar Matzinger, Wendy Jeanneret-Sozzi, François Bochud & Raphaël Moeckli. (2013) Evaluation of organ-specific peripheral doses after 2-dimensional, 3-dimensional and hybrid intensity modulated radiation therapy for breast cancer based on Monte Carlo and convolution/superposition algorithms: Implications for secondary cancer risk assessment. Radiotherapy and Oncology 106:1, pages 33-41.
Crossref
Crossref
B. Knäusl, C. Lütgendorf-Caucig, J. Hopfgartner, K. Dieckmann, L. Kurch, T. Pelz, R. Pötter & D. Georg. (2012) Can treatment of pediatric Hodgkin’s lymphoma be improved by PET imaging and proton therapy?Kann die Behandlung von pädiatrischen Hodgkin-Lymphomen durch PET-Bildgebung und Protonenbestrahlung verbessert werden?. Strahlentherapie und Onkologie 189:1, pages 54-61.
Crossref
Crossref
Mohamed Amine Benadjaoud, Jérémi Bezin, Attila Veres, Dimitri Lefkopoulos, Jean Chavaudra, André Bridier, Florent de Vathaire & Ibrahima Diallo. (2012) A multi-plane source model for out-of-field head scatter dose calculations in external beam photon therapy. Physics in Medicine and Biology 57:22, pages 7725-7739.
Crossref
Crossref
J.-Y. Park, J.-W. Lee, J.-B. Chung, K.-S. Choi, Y.-L. Kim, B.-M. Park, Y. Kim, J. Kim, J. Choi, J.-S. Kim, S. Hong & T.-S. Suh. (2012) Radiobiological model-based bio-anatomical quality assurance in intensity-modulated radiation therapy for prostate cancer. Journal of Radiation Research 53:6, pages 978-988.
Crossref
Crossref
M Hussein, S Aldridge, T Guerrero Urbano & A Nisbet. (2012) The effect of 6 and 15 MV on intensity-modulated radiation therapy prostate cancer treatment: plan evaluation, tumour control probability and normal tissue complication probability analysis, and the theoretical risk of secondary induced malignancies. The British Journal of Radiology 85:1012, pages 423-432.
Crossref
Crossref
M. Uhl, F. Sterzing, G. Habl, K. Schubert, H. Holger, J. Debus & K. Herfarth. (2012) Breast cancer and funnel chestBrustkrebs und Trichterbrust. Strahlentherapie und Onkologie 188:2, pages 127-135.
Crossref
Crossref
C Timlin, M Houston & B Jones. (2011) Malignant induction probability maps for radiotherapy using X-ray and proton beams. The British Journal of Radiology 84:special_issue_1, pages S70-S78.
Crossref
Crossref
Uwe Schneider, Marcin Sumila & Judith Robotka. (2011) Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy. Theoretical Biology and Medical Modelling 8:1.
Crossref
Crossref
Hojin Jeong, Jeong-Eun Rah, Ui-Jung Hwang, Seung Hoon Yoo, Byung Jun Min, Sang-Yeob Lee, Myonggeun Yoon, Dong Ho Shin, Sung Yong Park, Se Byeong Lee & Joo-Young Kim. (2011) Estimation of the secondary cancer risk induced by diagnostic imaging radiation during proton therapy. Journal of Radiological Protection 31:4, pages 477-487.
Crossref
Crossref
Uwe Schneider. (2011) Modeling the Risk of Secondary Malignancies after Radiotherapy. Genes 2:4, pages 1033-1049.
Crossref
Crossref
Damien C. Weber, Safora Johanson, Nicolas Peguret, Luca Cozzi & Dag R. Olsen. (2011) Predicted Risk of Radiation-Induced Cancers After Involved Field and Involved Node Radiotherapy With or Without Intensity Modulation for Early-Stage Hodgkin Lymphoma in Female Patients. International Journal of Radiation Oncology*Biology*Physics 81:2, pages 490-497.
Crossref
Crossref
A Joosten, F Bochud, S Baechler, F Levi, R-O Mirimanoff & R Moeckli. (2011) Variability of a peripheral dose among various linac geometries for second cancer risk assessment. Physics in Medicine and Biology 56:16, pages 5131-5151.
Crossref
Crossref
K. M. Winkfield, A. Niemierko, M. R. Bussière, E. M. Crowley, B. N. Napolitano, K. P. Beaudette, J. S. Loeffler & H. A. Shih. (2011) Modeling Intracranial Second Tumor Risk and Estimates of Clinical Toxicity with Various Radiation Therapy Techniques for Patients with Pituitary Adenoma. Technology in Cancer Research & Treatment 10:3, pages 243-251.
Crossref
Crossref
Alexandru Daşu, Iuliana Toma-Daşu, Lars Franzén, Anders Widmark & Per Nilsson. (2011) Secondary Malignancies From Prostate Cancer Radiation Treatment: A Risk Analysis of the Influence of Target Margins and Fractionation Patterns. International Journal of Radiation Oncology*Biology*Physics 79:3, pages 738-746.
Crossref
Crossref
Rungdham Takam, Eva Bezak, Eric E. Yeoh & Loredana Marcu. (2010) Assessment of normal tissue complications following prostate cancer irradiation: Comparison of radiation treatment modalities using NTCP models. Medical Physics 37:9, pages 5126-5137.
Crossref
Crossref
Birgitta Welte, Peter Suhr, Dirk Bottke, Detlef Bartkowiak, Wolfgang Dörr, Klaus Rüdiger Trott & Thomas Wiegel. (2010) Second Malignancies in High‑Dose Areas of Previous Tumor RadiotherapyZweitmalignome in Hochdosisbereich vorangegangener Strahlentherapie. Strahlentherapie und Onkologie 186:3, pages 174-179.
Crossref
Crossref
Asja Pfaffenberger, Uwe Schneider, Björn Poppe & Uwe Oelfke. (2009) Phenomenological modelling of second cancer incidence for radiation treatment planning. Zeitschrift für Medizinische Physik 19:4, pages 236-250.
Crossref
Crossref
Igor Shuryak, Philip Hahnfeldt, Lynn Hlatky, Rainer K. Sachs & David J. Brenner. (2009) A new view of radiation-induced cancer: integrating short- and long-term processes. Part II: second cancer risk estimation. Radiation and Environmental Biophysics 48:3, pages 275-286.
Crossref
Crossref
Daniel R. Zwahlen, Jeremy D. Ruben, Phillip Jones, Frank Gagliardi, Jeremy L. Millar & Uwe Schneider. (2009) Effect of Intensity-Modulated Pelvic Radiotherapy on Second Cancer Risk in the Postoperative Treatment of Endometrial and Cervical Cancer. International Journal of Radiation Oncology*Biology*Physics 74:2, pages 539-545.
Crossref
Crossref
Stephen F. Kry, Mohammad Salehpour, Uwe Titt, R. Allen White, Marilyn Stovall & David Followill. (2009) Monte Carlo study shows no significant difference in second cancer risk between 6- and 18-MV intensity-modulated radiation therapy. Radiotherapy and Oncology 91:1, pages 132-137.
Crossref
Crossref
Uwe Schneider. (2009) Mechanistic model of radiation-induced cancer after fractionated radiotherapy using the linear-quadratic formula. Medical Physics 36:4, pages 1138-1143.
Crossref
Crossref
R Takam, E Bezak & E E Yeoh. (2009) Risk of second primary cancer following prostate cancer radiotherapy: DVH analysis using the competitive risk model. Physics in Medicine and Biology 54:3, pages 611-625.
Crossref
Crossref
Abigail WaltonAndrew L. Broadbent. (2008) Radiation-Induced Second Malignancies. Journal of Palliative Medicine 11:10, pages 1345-1352.
Crossref
Crossref
Martin Hillbrand, Dietmar Georg, Helmut Gadner, Richard Pötter & Karin Dieckmann. (2008) Abdominal cancer during early childhood: A dosimetric comparison of proton beams to standard and advanced photon radiotherapy. Radiotherapy and Oncology 89:2, pages 141-149.
Crossref
Crossref
Uwe Schneider & Linda Walsh. (2007) Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy. Radiation and Environmental Biophysics 47:2, pages 253-263.
Crossref
Crossref
Daniel R. Zwahlen, Jarad M. Martin, Jeremy L. Millar & Uwe Schneider. (2008) Effect of Radiotherapy Volume and Dose on Secondary Cancer Risk in Stage I Testicular Seminoma. International Journal of Radiation Oncology*Biology*Physics 70:3, pages 853-858.
Crossref
Crossref
David J. Brenner & Igor Shuryak. 2008. Cured II ■ LENT Cancer Survivorship Research and Education. Cured II ■ LENT Cancer Survivorship Research and Education
33
40
.
Rainer K. Sachs, Igor Shuryak, David Brenner, Hatim Fakir, Lynn Hlatky & Philip Hahnfeldt. (2007) Second cancers after fractionated radiotherapy: Stochastic population dynamics effects. Journal of Theoretical Biology 249:3, pages 518-531.
Crossref
Crossref
Uwe Schneider, Antony Lomax, Jürgen Besserer, Peter Pemler, Norbert Lombriser & Barbara Kaser-Hotz. (2007) The Impact of Dose Escalation on Secondary Cancer Risk After Radiotherapy of Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics 68:3, pages 892-897.
Crossref
Crossref
Igor Shuryak, Rainer K. Sachs, Lynn Hlatky, Mark P. Little, Philip Hahnfeldt & David J. Brenner. (2006) Radiation-Induced Leukemia at Doses Relevant to Radiation Therapy: Modeling Mechanisms and Estimating Risks. JNCI: Journal of the National Cancer Institute 98:24, pages 1794-1806.
Crossref
Crossref
Eeva K. Salminen, Eero Pukkala, Krys D. Kiel & Timo T. Hakulinen. (2006) Impact of radiotherapy in the risk of esophageal cancer as subsequent primary cancer after breast cancer. International Journal of Radiation Oncology*Biology*Physics 65:3, pages 699-704.
Crossref
Crossref
Z Kote-Jarai, A Salmon, T Mengitsu, M Copeland, A Ardern-Jones, I Locke, S Shanley, B Summersgill, Y-J Lu, J Shipley & R Eeles. (2005) Increased level of chromosomal damage after irradiation of lymphocytes from BRCA1 mutation carriers. British Journal of Cancer 94:2, pages 308-310.
Crossref
Crossref